Obesity Identification, Communication, and Management fcaap

• Funding and Accreditation:

  • Funding Sponsor: Educational activity supported by a grant from Eli Lilly.

  • Providing Organization: Medical Learning Institute (MLI).

  • Accreditation: Continuing Medical Education (CME) credits are available for participating healthcare providers.

  • Online Tools: MLI provides downloadable clinical tools, educational materials, and lecture slides.

Epidemiology, Prevalence, and Disease Burden of Pediatric Obesity

• Epidemiology and Trajectory:

  • Crisis Acceleration: Pediatric obesity prevalence has worsened significantly following the COVID-19 pandemic.

  • Long-Term Risk Projections: Over $50\%$ of children between the ages of $2\text{ and }19\text{ years}$ are projected to have obesity by $35\text{ years of age}$.

  • Geographic Disparities: Florida ranks among the top $13\text{ states}$ in the United States for pediatric obesity prevalence.

  • Adult Persistence: Pediatric obesity does not self-resolve; children with obesity are highly likely to remain obese as adults.

• Physical Complications:

  • Short-Term Effects: Gastroesophageal reflux, altered or premature pubertal timing, reduced cardiorespiratory fitness, and impaired lung function.

  • Long-Term Cardiometabolic Effects: Significantly elevated risk for cardiovascular disease, type 2 diabetes mellitus, prediabetes, hepatic steatosis (fatty liver disease), dyslipidemia, and hypertension.

• Psychosocial and Mental Health Impact:

  • Mental Health Associations: Strongly linked to depression, anxiety, poor body image, and reduced health-related quality of life.

  • Stigma and Shame: High prevalence of weight-based discrimination, social isolation, teasing, and internalized shame among pediatric patients and their families.

Identification, Assessment, and Diagnostic Criteria

• Body Mass Index (BMI) Utilization:

  • Clinical Utility: Validated screening tool to monitor longitudinal growth trajectories, track treatment response, and initiate conversations regarding health.

  • Growth Curves: American Academy of Pediatrics (AAP) updated age- and sex-specific BMI growth charts.

  • Diagnostic Limitations: BMI does not differentiate fat mass from nonfat (lean skeletal muscle) body mass.

• Body Composition Modalities:

  • Clinical Rationale: Evaluating fat mass versus nonfat mass allows accurate differentiation of athletic/muscular individuals with elevated BMI from those with excess adiposity.

  • Dual-Energy X-Ray Absorptiometry (DEXA): Gold-standard diagnostic assessment tool utilized in pediatric endocrinology and clinical research; limited accessibility in general primary care.

  • Bioelectrical Impedance Analysis (BIA): Increasingly cost-effective, practical point-of-care tool for direct body composition measurement in outpatient pediatric clinics.

• Diagnostic Cutoffs and Guidelines:

  • AAP Guidelines: The $2023\text{ AAP guidelines}$ (updating prior $2007\text{ guidelines}$) establish a diagnostic classification threshold starting at greater than the $90\text{th}\text{ percentile}$ for age and sex.

• Patient History and Risk Stratification:

  • Modifiable Risk Factors: Dietary intake, physical activity levels, screen time duration, sleep duration and quality (sleep disruption directly impacts metabolic regulation), ulcerogenic or hyperphagic medications (e.g., atypical antipsychotics), and Social Determinants of Health (SDOH).

  • Non-Modifiable Risk Factors: Genetic susceptibility and family history of early-onset cardiometabolic disease or bariatric interventions. Screening for monogenic obesity syndromes is indicated in specific early-onset presentations.

Barriers to Identification and Screening Challenges

• Underdiagnosis Statistics:

  • Prevalence of Underdiagnosis: Between $25\%$ and $56\%$ of pediatric patients who meet diagnostic criteria for obesity do not receive a formal clinical diagnosis in their medical record.

• Systemic and Clinical Barriers:

  • Cutoff Inconsistencies: Inconsistent application of age- and sex-specific BMI growth curves directly contributes to ongoing underdiagnosis.

  • Visit Constraints: Competing priorities within brief annual well-child visits hinder dedicated discussion time.

  • Societal Stigma and Resistance: Anticipated parental resistance, weight bias, and uncomfortable dynamics around weight discussions.

  • Clinical Misconceptions: The persistent belief that children will "outgrow" excess weight is contradicted by clinical evidence.

• Clinical Imperative:

  • Proactive screening and early diagnosis must replace watchful waiting to prevent unmonitored progression of cardiometabolic complications.

  • Recommended initial screening panel: Fasting lipid panel, comprehensive metabolic panel (CMP for hepatic transaminases), and hemoglobin $HbA1c$.

Communication Strategies and Motivational Interviewing (MI)

• Timing of Intervention:

  • Target Age: Addressing growth trends and metabolic health should begin prior to $3\text{ years of age}$.

  • Current Practice Gap: Clinicians typically delay explicit obesity discussions until patients reach an average age of nearly $11\text{ years of age}$.

  • Early Onset Comorbidities: Type 2 diabetes mellitus has been diagnosed in children as young as $6\text{ years of age}$.

• Motivational Interviewing Framework:

  • Patient-Centered Coaching: The clinician acts as a "coach" or